Structures by: Keppler B. K.
Total: 265
(OC-6-44)-Diamminedichloridomethoxido[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethylcarbamato]platinum(IV)
C8H16Cl2N4O5Pt
Chem. Sci. (2017) 8, 3 2241
a=12.2584(7)Å b=10.9135(6)Å c=21.9058(13)Å
α=90° β=104.6597(18)° γ=90°
(OC-6-44)-Acetatodiamminedichlorido[2-(2,5-dioxopyrrolidin-1-yl)ethyl)carbamato]platinum(IV)
C9H18Cl2N4O6Pt,H2O
Chem. Sci. (2017) 8, 3 2241
a=27.345(5)Å b=10.1753(11)Å c=12.3345(13)Å
α=90° β=101.328(5)° γ=90°
(OC-6-22)-((1R,2R)-diaminocyclohexane)bis(oxalato)platinum(IV)
C10H14N2O8Pt,2(C3H7NO)
Journal of medicinal chemistry (2014) 57, 15 6751-6764
a=8.9059(5)Å b=11.2218(6)Å c=22.0760(11)Å
α=90.00° β=90.00° γ=90.00°
(OC-6-22)-ethane-1,2-diamine(3-methylmalonato)platinum(IV)
C10H16,N2O8Pt,C3H7NO,C3H6O,H2O
Journal of medicinal chemistry (2014) 57, 15 6751-6764
a=13.8623(4)Å b=8.6180(2)Å c=18.7397(5)Å
α=90.00° β=97.8410(10)° γ=90.00°
[Chlorido(hapto^6^-p-cymene)(N-{4-hydroxyphenyl}-2-pyridinecarbothioamide)osmium(II)] chloride
c22H24ClN2OOsS,Cl
Chemical Science (2013) 4, 4 1837
a=14.4797(14)Å b=11.9305(11)Å c=13.1126(13)Å
α=90.00° β=98.591(3)° γ=90.00°
[Chlorido(hapto^6^-p-cymene)(N-{4-fluorophenyl}-2-pyridinecarbothioamide)ruthenium(II)] chloride
C22H23ClFN2RuS,C3H6O,Cl
Chemical Science (2013) 4, 4 1837
a=14.0346(9)Å b=8.6278(5)Å c=22.7026(13)Å
α=90.00° β=90.353(3)° γ=90.00°
Dichlorido(1,3,5-Triaza-7-phosphatricyclo[3.3.1.13.7]decane)(h6-benzylammonium)ruthenium(II)
C13H22Cl2N4PRu,CH4O,Cl
Chem. Sci. (2015) 6, 4 2449
a=6.9163(14)Å b=23.660(4)Å c=11.8396(19)Å
α=90.00° β=97.078(9)° γ=90.00°
Dichlorido(1,3,5-Triaza-7-phosphatricyclo[3.3.1.13.7]decane)(h6-N-benzylacetamide)ruthenium(II)
C15H23Cl2N4OPRu
Chem. Sci. (2015) 6, 4 2449
a=10.5379(5)Å b=12.8283(6)Å c=13.7451(7)Å
α=100.766(2)° β=97.279(2)° γ=91.491(2)°
(OC-6-33)-Dichlorido(ethane-1,2-diamine)bis{(4-methoxy)-4- oxobutanoato}platinum(IV)
C12H22Cl2N2O8Pt
Journal of medicinal chemistry (2013) 56, 1 330-344
a=8.2185(3)Å b=10.0375(4)Å c=12.4165(5)Å
α=67.002(3)° β=71.136(2)° γ=84.577(3)°
(OC-6-54)-Dichlorido(N,N-dimethyl-ethane-1,2-diamine)aquamethoxidoplatinum(IV) trifluoroacetate
C5H17Cl2N2O2Pt,C2F3O2
Journal of medicinal chemistry (2012) 55, 24 11052-11061
a=6.1836(2)Å b=8.0658(3)Å c=15.5374(7)Å
α=102.217(3)° β=92.750(3)° γ=108.655(2)°
3-Aminopyridine-2-carbaldehyde thiosemicarbazone
C7H9N5S
Journal of medicinal chemistry (2009) 52, 16 5032-5043
a=18.5732(8)Å b=5.5273(2)Å c=17.2799(7)Å
α=90.00° β=90.00° γ=90.00°
Pyridine-2-carbaldehyde N,N-dimethylthiosemicarbazone
C9H12N4S
Journal of medicinal chemistry (2009) 52, 16 5032-5043
a=7.3747(2)Å b=7.4532(2)Å c=9.6324(3)Å
α=97.192(2)° β=109.630(2)° γ=95.020(2)°
C14H16GaN10S2,C2H6O,NO3
C14H16GaN10S2,C2H6O,NO3
Journal of medicinal chemistry (2009) 52, 16 5032-5043
a=9.3441(7)Å b=9.7491(10)Å c=12.9501(13)Å
α=102.437(6)° β=95.239(5)° γ=96.569(5)°
[Bis(3-aminopyridine-2-carbaldehyde thiosemicarbazonato)- N,N,S-iron(III)] nitrate hydrate
2(C14H16FeN10S2),NO6,NO3,4(H2O)
Journal of medicinal chemistry (2009) 52, 16 5032-5043
a=9.2033(4)Å b=23.0998(11)Å c=21.2104(8)Å
α=90.00° β=92.473(3)° γ=90.00°
Trans-[Dichlorotetraindazoleruthenium(III)]chloride methanol disolvate
C30H32Cl3N8O2Ru
Journal of medicinal chemistry (2005) 48, 8 2831-2837
a=17.681(4)Å b=11.082(2)Å c=16.738(3)Å
α=90.00° β=102.46(3)° γ=90.00°
Trans-[Dichlorotetraindazoleruthenium(II)]acetone disolvate
C34H36Cl2N8O2Ru
Journal of medicinal chemistry (2005) 48, 8 2831-2837
a=10.891(2)Å b=13.279(3)Å c=14.399(3)Å
α=65.66(3)° β=69.04(3)° γ=68.36(3)°
(OC-6-33)-Diamminebis(3-carboxypropanoato)dichloroplatinum(IV) diethyl ether solvate
C12H26Cl2N2O9Pt
Journal of medicinal chemistry (2007) 50, 26 6692-6699
a=23.5231(10)Å b=10.6395(4)Å c=8.1822(3)Å
α=90.00° β=90.00° γ=90.00°
9-Nitro-6-(alpha-picolylamino)-7,12-dihydroindolo[3,2-d][1]benzazepine
C22H17N5O2
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=10.8951(10)Å b=20.050(2)Å c=8.6412(9)Å
α=90.00° β=90.160(4)° γ=90.00°
(hapto^6^-p-Cymene)[9-pyridin-kappaN-2-yl-(E)-methylidene)amino-kappaN-7,12- dihydroindolo[3,2-d][1]benzazepin-6(5H)-one]chloroosmium(II) chloride acetone solvate
C35H36Cl2N4O2Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=9.876(2)Å b=9.6263(19)Å c=17.460(4)Å
α=90.00° β=104.32(3)° γ=90.00°
(hapto^6^-p-Cymene)[9-pyridin-kappaN-2-yl-(E)-methylidene)amino-kappaN-7,12- dihydroindolo[3,2-d][1]benzazepin-6(5H)-one]chlororuthenium(II) chloride acetone solvate
C35H36Cl2N4O2Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=9.872(2)Å b=9.6208(19)Å c=17.434(4)Å
α=90.00° β=104.05(3)° γ=90.00°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chlororuthenium(II) chloride diethanol solvate
C36H43Cl2N5O4Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=12.2485(4)Å b=12.6418(5)Å c=14.3132(5)Å
α=95.421(2)° β=108.122(2)° γ=118.054(2)°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chlororuthenium(II) chloride diethanol water solvate
C36H45Cl2N5O5Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=10.771(2)Å b=25.040(5)Å c=13.238(3)Å
α=90.00° β=91.84(3)° γ=90.00°
(hapto^6^-p-Cymene){9-bromo-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride ethanol water solvate
C130H133Br4Cl8N16O3.5Os4
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=13.8319(5)Å b=14.1376(5)Å c=18.3912(6)Å
α=98.511(2)° β=107.338(2)° γ=102.012(2)°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride ethanol water solvate
C35.9H42.95Cl2N5O4.08Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=12.2836(4)Å b=12.6756(4)Å c=14.2592(6)Å
α=95.491(2)° β=107.998(2)° γ=118.072(2)°
(hapto^6^-p-Cymene){6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride water solvate
C32H32.5Cl2N4O0.25Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=13.9580(7)Å b=14.0949(7)Å c=18.3531(9)Å
α=96.749(3)° β=108.022(3)° γ=102.050(3)°
Bis[((1-benzyl-2-methyl-3-(oxo-κO)-pyridine-4(1H)- thionato-κS)(η6-p-cymene) ruthenium(II)) iodide]
2(I),C46H52N2O2Ru2S2,CH4O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=19.6766(16)Å b=10.0026(10)Å c=24.018(2)Å
α=90° β=92.308(4)° γ=90°
[(Thioatocarbonyldiamine-κS)(1-benzyl-2-methyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)](η6-p-cymene)ruthenium(II)] chloride
C24H30N3ORuS2,Cl
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=10.107(2)Å b=11.107(2)Å c=12.096(2)Å
α=90° β=108.775(8)° γ=90°
[(1-Methyl-1H-imidazole-κN3)(1,2-dimethyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η6-p-cymene)ruthenium(II)] hexafluorophosphate
C21H28N3ORuS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=9.5074(2)Å b=10.0971(3)Å c=13.5952(4)Å
α=74.3060(9)° β=77.5332(9)° γ=87.8246(11)°
[(1,3,5-Triaza-7-phosphaadamantane-κP)(1,2-Dimethyl-3-oxo-κO-pyridine- 4(1H)-thionato-κS)(η6-p-cymene)ruhtenium(II)] hexafluorophosphate
C23H34N4OPRuS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=8.8476(5)Å b=11.4425(6)Å c=13.8462(7)Å
α=82.475(2)° β=79.907(2)° γ=88.353(2)°
[(1-Methyl-1H-imidazole-κN3)(1-benzyl-2-methyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)] hexafluorophosphate
C27H33N3ORhS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=9.8382(3)Å b=12.2093(4)Å c=14.1367(5)Å
α=67.1738(11)° β=80.8485(12)° γ=68.3017(11)°
[(1-Methyl-1H-imidazole-κN3)(1-benzyl-2-methyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η6-p-cymene)ruhtenium(II)] hexafluorophosphate
C27H32N3ORuS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=10.3415(3)Å b=11.8930(3)Å c=13.3257(4)Å
α=67.1050(10)° β=88.0280(10)° γ=76.6230(10)°
[(1-Methyl-1H-imidazole-κN3)(1-benzyl-2-methyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)iridium(III)] hexafluorophosphate
C27H33IrN3OS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=9.8020(5)Å b=12.3228(6)Å c=13.9774(7)Å
α=68.0585(16)° β=81.3239(17)° γ=69.4402(17)°
[(1,3,5-Triaza-7-phosphaadamantane-κP)(1-benzyl-2-methyl-3-oxo-κO-pyridine- 4(1H)-thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)] hexafluorophosphate
C29H39N4OPRhS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=9.4865(4)Å b=13.5259(8)Å c=13.5730(8)Å
α=68.784(2)° β=84.539(3)° γ=78.200(3)°
[(1-Methyl-1H-imidazole-κN3)(1,2-dimethyl-3-oxo-κO-pyridine-4(1H)-thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)] hexafluorophosphate
C21H29N3ORhS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=8.7282(5)Å b=16.3364(10)Å c=17.8947(11)Å
α=93.913(2)° β=97.756(2)° γ=90.927(3)°
[(1,3,5-Triaza-7-phosphaadamantane-κP)(1,2-Dimethyl-3-oxo-κO-pyridine-4(1H)-thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)]hexafluorophosphate
0.5(C23H35N4OPRhS),0.5(C23H34N4OPRhS),F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=21.070(3)Å b=9.9943(14)Å c=31.846(4)Å
α=90° β=99.318(5)° γ=90°
[(1,3,5-Triaza-7-phosphaadamantane-κP)(1-benzyl-2-methyl-3-oxo-κO-pyridine- 4(1H)-thionato-κS)(η6-p-cymene)ruthenium(II)] hexafluorophosphate
C29H38N4OPRuS,2(CH2Cl2),F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=12.3099(3)Å b=12.4123(4)Å c=14.4636(4)Å
α=65.2024(11)° β=70.4638(11)° γ=77.0040(11)°
[(1-Methyl-1H-imidazole-κN3)(1,2-dimethyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)iridium(III)] hexafluorophosphate
C21H29IrN3OS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=8.77040(10)Å b=16.4092(2)Å c=18.0771(3)Å
α=93.7892(5)° β=97.5756(5)° γ=90.7492(5)°
[(3-Methyl-4-oxo-(1H-κN2-pyrazol-1-yl)-1,4-dihydronaphtalene-1,2-bis(olato)-κO1-κO2)(η6-p-cymene)ruthenium(II)]
C24H24N2O3Ru,C3H6O,H2O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=32.8559(11)Å b=8.4989(4)Å c=18.2283(7)Å
α=90° β=96.9960(17)° γ=90°
[(3-Methyl-1-(4-methyl-1H-κN2-pyrazol-1-yl)-4-oxo-1,4-dihydronaphtalene-1,2-bis(olato)-κO1-κO2)(η6-p-cymene)osmium(II)]
C25H26N2O3Os
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=16.3690(9)Å b=7.6784(4)Å c=18.1186(10)Å
α=90° β=110.5999(13)° γ=90°
3-methyl-1-(4-methyl-1H-κN2-pyrazol-1-yl)-4-oxo-1,4-dihydronaphthalene-1,2-bis(olato)-κO1-κO2)(η6-p-cymene)ruthenium(II)
C25H26N2O3Ru
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=9.6758(2)Å b=14.2466(3)Å c=17.8729(4)Å
α=71.6959(13)° β=84.0849(14)° γ=72.7405(13)°
[(1-(1H-κN2-indazol-1-yl)-3-methyl-4-oxo-1,4-dihydronaphtalene-1,2-bis(olato)-κO1-κO2))(η6-p-cymene)ruthenium(II)]
C28H26N2O3Ru,0.09(C8H20O2)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=11.4410(2)Å b=15.6073(3)Å c=17.4184(3)Å
α=107.7827(7)° β=99.4000(7)° γ=108.5729(6)°
[(1-(6-amino-1H-κN2-indazol-1-yl)-3-methyl-4-oxo-1,4-dihydronaphtalene-1,2-bis(olato)-κO1-κO2))(η6-p-cymene)ruthenium(II)]
C28H27N3O3Ru
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=10.9871(9)Å b=9.5021(7)Å c=27.626(2)Å
α=90° β=98.361(3)° γ=90°
[(3-Methyl-4-oxo-(1H-κN2-pyrazol-1-yl)-1,4-dihydronaphtalene -1,2-bis(olato)-κO1-κO2)(η6-p-cymene)osmium(II)]
C24H24N2O3Os,H2O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=11.8354(6)Å b=14.6547(7)Å c=12.6306(6)Å
α=90° β=110.4966(15)° γ=90°
[(1-(1H-κN2-indazol-1-yl)-3-methyl-4-oxo-1,4-dihydronaphtalene-1,2-bis(olato)-κO1-κO2))(η6-p-cymene)osmium(II)]
C28H26N2O3Os
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=11.4724(3)Å b=15.5715(4)Å c=17.4570(5)Å
α=107.6878(10)° β=99.3524(10)° γ=108.3467(10)°
[(1-(4-amino-1H-κN2-pyrazol-1-yl)-3-methyl-4-oxo-1,4-dihydronaphtalene-1,2-bis(olato)-κO1-κO2))(η6-p-cymene)ruthenium(II)]
C24H25N3O3Ru
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=11.3136(9)Å b=23.5155(17)Å c=17.8647(15)Å
α=90° β=102.414(3)° γ=90°
[(Chlorido)(1,3-dioxo-kO1-1,3-dihydro-2H-inden-2-ylidene)((2-(naphthalen-1-yl)ethyl)amino)methanolato-kO2)](c6-p-cymene)ruthenium(II)
C32H30ClNO3Ru,0.67(H2O)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 32 12040-12049
a=20.9813(8)Å b=10.3997(4)Å c=14.4831(5)Å
α=90° β=117.7999(10)° γ=90°
[(Chlorido)(1,3-dioxo-kO1-1,3-dihydro-2H-inden-2-ylidene)((2-(naphthalen-1-yl)methyl)amino)methanolato-kO2)](c6-p-cymene)ruthenium(II)
C31H28ClNO3Ru
Dalton transactions (Cambridge, England : 2003) (2019) 48, 32 12040-12049
a=22.1184(8)Å b=10.0442(3)Å c=24.5438(9)Å
α=90° β=105.602(2)° γ=90°
[(kN2-Pyridine)(1,3-dioxo-kO1-1,3-dihydro-2H-inden-2-ylidene)((2-(naphthalen-1-yl)methyl)amino)methanolato-kO2)](c6-p-cymene)ruthenium(II)
C36H33N2O3Ru,F6P
Dalton transactions (Cambridge, England : 2003) (2019) 48, 32 12040-12049
a=13.8315(10)Å b=15.1456(7)Å c=16.7083(11)Å
α=90° β=109.345(2)° γ=90°
C5H14Cl2N2O2PtS
C5H14Cl2N2O2PtS
New Journal of Chemistry (2017) 41, 14 6840
a=7.7950(7)Å b=8.6094(9)Å c=9.4837(9)Å
α=99.166(8)° β=91.628(8)° γ=114.355(9)°
C10H13Cl2F3N2O2PtS
C10H13Cl2F3N2O2PtS
New Journal of Chemistry (2017) 41, 14 6840
a=7.1487(4)Å b=8.9180(5)Å c=13.5059(9)Å
α=82.385(5)° β=87.679(5)° γ=66.909(6)°
C9H22N2O3PtS2
C9H22N2O3PtS2
New Journal of Chemistry (2017) 41, 14 6840
a=9.3250(8)Å b=18.8767(15)Å c=17.497(2)Å
α=90° β=90° γ=90°
C4H12Cl2N2O2PtS
C4H12Cl2N2O2PtS
New Journal of Chemistry (2017) 41, 14 6840
a=8.0458(6)Å b=11.8336(7)Å c=12.2420(15)Å
α=90° β=112.759(8)° γ=90°
C9H14Cl2N2O2PtS,CH4O
C9H14Cl2N2O2PtS,CH4O
New Journal of Chemistry (2017) 41, 14 6840
a=7.7751(2)Å b=15.9278(5)Å c=13.8379(4)Å
α=90° β=103.110(3)° γ=90°
C2H6Cl3OPtS,C5H13N2O
C2H6Cl3OPtS,C5H13N2O
New Journal of Chemistry (2017) 41, 14 6840
a=6.5859(2)Å b=19.2634(7)Å c=12.7960(5)Å
α=90° β=116.115(3)° γ=90°
2,3-{(R,S)-(ferrocene-1,1'-dicarbonyl)}-O-methyl-alpha-D-glucopyranoside
C19H20FeO8.H2O
New Journal of Chemistry (2002) 26, 6 671
a=5.8080(10)Å b=10.750(2)Å c=14.772(3)Å
α=90.00° β=93.44(3)° γ=90.00°
Trans_[PtCl4{NH=C(Me)ON=C(Me)C(Me)(O)}2]
C12H20Cl4N4O4Pt
New Journal of Chemistry (2002)
a=6.1415(2)Å b=15.0031(4)Å c=11.3715(2)Å
α=90.00° β=101.215(2)° γ=90.00°
trans-(PtCl4{NH=C(Et)ON=C(Me)C(Ph)(=O)}2]
C24H28Cl4N4O4Pt
New Journal of Chemistry (2002)
a=7.8552(2)Å b=8.5681(2)Å c=11.6142(3)Å
α=88.8886(12)° β=74.9911(12)° γ=73.4238(12)°
Trans-(PtCl4{NH=C(Et)ON=C(Me)C(C6H4F-p)(=O)}2]
C24H26Cl4F2N4O4Pt
New Journal of Chemistry (2002)
a=7.4829(15)Å b=12.489(3)Å c=16.111(3)Å
α=71.07(3)° β=86.40(3)° γ=86.11(3)°
[Rh (n5-C5Me5)(dmen)Cl](CF3SO3)
C14H27ClN2Rh,CF3O3S
New Journal of Chemistry (2018) 42, 13 11174
a=8.5159(3)Å b=9.7262(4)Å c=24.5900(10)Å
α=90° β=90° γ=90°
[Rh(n5-C5Me5)(pin)Cl](Cl)
2(C16H23ClN2Rh),0.5(C2H8O2),2(Cl)
New Journal of Chemistry (2018) 42, 13 11174
a=8.6742(3)Å b=14.5573(6)Å c=14.6705(6)Å
α=90° β=104.1107(13)° γ=90°
[Rh(n5-C5Me5)(tmeda)Cl](CF3SO3)
3(C16H31ClN2Rh),3(CF3O3S),2(H2O)
New Journal of Chemistry (2018) 42, 13 11174
a=13.0112(4)Å b=37.6730(11)Å c=13.6054(4)Å
α=90° β=91.5748(9)° γ=90°
Trans-[PtCl2{NH=C(Et)ON=C(Me)C(Me)(=O)}2]
C14H24Cl2N4O4Pt
New Journal of Chemistry (2002) 26, 8 1085
a=6.14820(10)Å b=9.4605(2)Å c=17.0184(3)Å
α=90.00° β=96.5058(9)° γ=90.00°
[Fe(p-hydrocoumaric hydroxamate)3]
C27H30FeN3O9,2(H2O)
RSC Advances (2016) 6, 46 40238
a=15.9200(7)Å b=11.6967(5)Å c=15.9254(6)Å
α=90° β=104.5149(15)° γ=90°
[Fe(3-hydroxybenzoic hydroxamate)3]
C21H18FeN3O9,2(C3H6O)
RSC Advances (2016) 6, 46 40238
a=11.1864(4)Å b=21.2415(7)Å c=25.3894(9)Å
α=90° β=90° γ=90°
[Fe2(hypogallic hydroxamate)4Cl2]
C28H24Cl2Fe2N4O16,2(C4H10O),2(CH4O)
RSC Advances (2016) 6, 46 40238
a=12.4686(6)Å b=11.1309(5)Å c=17.4694(10)Å
α=90° β=94.456(3)° γ=90°
[Fe(salicylic hydroxamate)3]
C21H18FeN3O9,1.5(C3H6O)
RSC Advances (2016) 6, 46 40238
a=23.1974(8)Å b=13.7678(8)Å c=22.3320(11)Å
α=90° β=109.575(3)° γ=90°
[Fe(cinammic hydroxamate)3]
C27H24FeN3O6,C1.2H4.4O,0.3(C2H6O)
RSC Advances (2016) 6, 46 40238
a=16.0853(15)Å b=28.696(3)Å c=7.0062(6)Å
α=90° β=96.758(3)° γ=90°
[Fe(eudesmic hydroxamate)3]
C30H36FeN3O15,4(H2O)
RSC Advances (2016) 6, 46 40238
a=12.0485(7)Å b=13.2910(7)Å c=13.4446(7)Å
α=69.9928(19)° β=78.6474(19)° γ=68.339(2)°
(OC-6-33)-Dichlorido(ethane-1,2-diamine)[bis(2-(2,5-dioxo-2,5- dihydro-1H-pyrrol-1-yl)ethylcarbamoyloxy)platinum(IV)]
C16H22Cl2N6O8Pt
Chemical communications (Cambridge, England) (2013) 49, 22 2249-2251
a=26.9636(16)Å b=7.7770(4)Å c=11.3395(6)Å
α=90.00° β=106.782(2)° γ=90.00°
C34H41ClN3P2Ru,BF4
C34H41ClN3P2Ru,BF4
Dalton transactions (Cambridge, England : 2003) (2007) 43 5065-5072
a=13.6698(10)Å b=14.4658(9)Å c=17.1533(6)Å
α=90.00° β=99.576(5)° γ=90.00°
Bis(diammine)(hapto$6!-p-cymene)chlorido-ruthenium(ii) hexafluorophosphate
C10H20ClN2Ru,F6P
Dalton Transactions (2009) 17 3334-3339
a=8.0544(2)Å b=8.8166(2)Å c=11.2876(3)Å
α=87.861(2)° β=88.256(2)° γ=78.272(2)°
Tris(mu!2$-methoxido)-bis(hapto$6!-p-cymene)-di-osmium(ii) hexafluorophosphate
C23H37O3Os2,F6P
Dalton Transactions (2009) 17 3334-3339
a=11.2483(3)Å b=13.6694(4)Å c=34.2630(9)Å
α=90.00° β=90.00° γ=90.00°
Bis(2,3,5,6,8,9-hexahydro-1,4,7,10-benzotetraoxacyclododecin- 12-aminium) hexafluorosilicate dihydrate
2(C12H18NO4),F6Si,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 27 2915-2924
a=21.8548(6)Å b=8.0635(2)Å c=8.5300(2)Å
α=90.00° β=98.599(2)° γ=90.00°
Bis(1,4,7-trioxa-10-azoniacyclododecane) bis(aquapentafluorosilicate) trihydrate
2(C8H18NO3),2(F5H2O1Si1),2(H2O1),O1
Dalton transactions (Cambridge, England : 2003) (2007) 27 2915-2924
a=14.8889(7)Å b=9.3635(5)Å c=20.3291(9)Å
α=90.00° β=93.900(3)° γ=90.00°
Cis,cis,cis- dichlorobis(dimethylsulfoxide)bis(indazole)ruthenium(ii)
C18H24Cl2N4O2RuS2
Dalton transactions (Cambridge, England : 2003) (2005) 14 2355-2364
a=12.194(2)Å b=12.888(3)Å c=14.720(3)Å
α=90.00° β=107.68(3)° γ=90.00°
Trans,cis,cis- dichlorobis(dimethylsulfoxide)bis(indazole)ruthenium(ii)
C18H24Cl2N4O2RuS2
Dalton transactions (Cambridge, England : 2003) (2005) 14 2355-2364
a=11.833(2)Å b=13.477(3)Å c=16.340(3)Å
α=113.96(3)° β=97.57(3)° γ=104.00(3)°
Trans,trans,trans- dichlorobis(dimethylsulfoxide)bis(indazole)ruthenium(ii)
C22H36Cl2N4O4RuS4
Dalton transactions (Cambridge, England : 2003) (2005) 14 2355-2364
a=27.0678(5)Å b=7.8991(5)Å c=14.0096(3)Å
α=90.00° β=94.1198(12)° γ=90.00°
Trans-dichlorobis(dimethylsulfoxide)amidineruthenium(ii) monohydrate
C13H23Cl2N3O3RuS2
Dalton transactions (Cambridge, England : 2003) (2005) 14 2355-2364
a=17.726(4)Å b=8.367(2)Å c=14.415(3)Å
α=90.00° β=113.56(3)° γ=90.00°
Trans- dichloro(dimethylsulfoxide)(indazole)amidineruthenium(ii) acetonitrile
C20H24Cl2N6ORuS
Dalton transactions (Cambridge, England : 2003) (2005) 14 2355-2364
a=12.235(2)Å b=14.800(3)Å c=13.614(3)Å
α=90.00° β=105.69(3)° γ=90.00°
C9H13Cl2N3O4PtS
C9H13Cl2N3O4PtS
New Journal of Chemistry (2017) 41, 14 6840
a=7.0238(3)Å b=9.0811(4)Å c=12.9083(3)Å
α=91.147(3)° β=94.584(3)° γ=111.834(4)°
C11H17N3O5PtS2
C11H17N3O5PtS2
New Journal of Chemistry (2017) 41, 14 6840
a=8.7261(2)Å b=10.2167(3)Å c=18.8842(4)Å
α=74.480(2)° β=80.247(2)° γ=87.869(2)°
[((2-κN)-1H-Indazole)(1-benzyl-4-(2-κC)-phenyl-1,2,3-(3-κN)-triazolato)(η6-p-cymene)ruthenium(II)] nitrate
2(C32H32N5Ru),H2O,2(NO3)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 13 4625-4638
a=10.6875(11)Å b=22.259(2)Å c=25.861(3)Å
α=90° β=90.648(4)° γ=90°
[(S-(Methylsulfanyl)methane)(1-benzyl-4-(2-\?C)-phenyl-1,2,3-(3-\?N)-triazolato)(\?6-p-cymene)ruthenium(II)] nitrate
C27H32N3RuS,NO3
Dalton transactions (Cambridge, England : 2003) (2018) 47, 13 4625-4638
a=9.8204(5)Å b=11.5773(6)Å c=15.0588(9)Å
α=98.178(2)° β=107.253(2)° γ=113.792(2)°
[(κN-1,3-Benzothiazole)(1-benzyl-4-(2-κC)-phenyl-1,2,3-(3-κN)-triazolato)(η6-p-cymene)ruthenium(II)] nitrate
C32H31N4RuS,CH2Cl2,NO3,0.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 13 4625-4638
a=12.0373(8)Å b=13.4469(8)Å c=20.7463(15)Å
α=95.649(2)° β=95.099(3)° γ=98.748(2)°
Fac,cis-[RuII(CO)3Cl2(MBI)]
C11H8Cl2N2O3Ru
Dalton transactions (Cambridge, England : 2003) (2017) 46, 9 3025-3040
a=7.4138(9)Å b=20.935(3)Å c=9.771(1)Å
α=90.00° β=109.94(1)° γ=90.00°
Cis,trans-[RuII(CO)2Cl2(MBI)2]
C18H16Cl2N4O2Ru
Dalton transactions (Cambridge, England : 2003) (2017) 46, 9 3025-3040
a=12.818(5)Å b=11.653(5)Å c=13.918(5)Å
α=90.00° β=105.766(5)° γ=90.00°
Fac,cis-[RuII(CO)3Cl2(DMBI)]
C12H10Cl2N2O3Ru
Dalton transactions (Cambridge, England : 2003) (2017) 46, 9 3025-3040
a=10.4194(3)Å b=10.4212(4)Å c=14.7120(5)Å
α=90.00° β=90.00° γ=90.00°
1,1ï-bis(4,6-dimethyl-1,3-dioxane-2-yl)-ferrocene
C22H30FeO4
Dalton Transactions (2003) 15 3098
a=10.2611(2)Å b=10.3294(2)Å c=19.0505(4)Å
α=90.00° β=90.00° γ=90.00°
1,1ï-bis(4,6-dimethyl-1,3-dioxane-2-yl)-ferrocene
C22H30FeO4
Dalton Transactions (2003) 15 3098
a=10.2840(4)Å b=10.9921(3)Å c=17.9147(7)Å
α=90.00° β=90.00° γ=90.00°
1,1ï-bis(1,3-dioxane-2-yl)-ferrocene
C18H22FeO4
Dalton Transactions (2003) 15 3098
a=5.8860(10)Å b=27.628(6)Å c=9.673(2)Å
α=90.00° β=93.50(3)° γ=90.00°
1,1ï-bis(1,3-dithiane-2-yl)-ferrocene
C18H22FeS4
Dalton Transactions (2003) 15 3098
a=12.203(2)Å b=18.686(4)Å c=9.861(2)Å
α=90.00° β=125.43(3)° γ=90.00°
(OC-6-43)-Dichlorido(N,N-dimethyl-ethane-1,2-diamine)dihydro- xidoplatinum(IV)
C4H14Cl2N2O2Pt
Dalton transactions (Cambridge, England : 2003) (2011) 40, 32 8187-8192
a=23.064(5)Å b=23.064(5)Å c=7.5597(16)Å
α=90.00° β=90.00° γ=90.00°
(OC-6-43)-Dichlorido(N,N-dimethyl-ethane-1,2- diamine)hydroxido(4-methoxy-4-oxobutanoato)platinum(IV)
C9H20Cl2N2O5Pt
Dalton transactions (Cambridge, England : 2003) (2011) 40, 32 8187-8192
a=8.1295(3)Å b=8.3664(3)Å c=11.0750(4)Å
α=89.567(3)° β=79.707(2)° γ=84.467(2)°
C19H23Cl2O6OsP,0.35(O)
C19H23Cl2O6OsP,0.35(O)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 31 7345-7352
a=8.7180(4)Å b=14.8768(7)Å c=17.0012(8)Å
α=90.00° β=90.00° γ=90.00°
3-Aminopyridine-2-carbaldehyde-thiosemicarbazone-dichlorido- zinc(ii) monoethanol solvate
C7H9Cl2N5SZn,C2H6O
Dalton transactions (Cambridge, England : 2003) (2010) 39, 3 704-706
a=11.4639(7)Å b=10.2716(5)Å c=12.7509(7)Å
α=90.00° β=99.422(4)° γ=90.00°
Bis(ethane-1,2-diamine-1kappa$2!N,N',2kappa$2!N,N')bis(miu-1- methylcytosinato-ka N3,N4)diplatinum(ii) dinitrate hydrate
2(C14H28N10O2Pt2),4(NO3),HO,4(H2O),2(O)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 15 3633-3643
a=25.8439(13)Å b=16.1026(11)Å c=18.3805(12)Å
α=90.00° β=132.070(6)° γ=90.00°
Chlorido(ethane-1,2-diamine)(1-methylcytosine)platinum(ii) nitrate acetone solvate
C7H15ClN5OPt,0.5(C6H12O2),NO3
Dalton transactions (Cambridge, England : 2003) (2010) 39, 15 3633-3643
a=7.5962(5)Å b=8.4624(5)Å c=13.6279(10)Å
α=76.987(4)° β=77.081(4)° γ=86.098(4)°
Aqua-1kappaO)bis(ethane-1,2-diamine- 1kappa$2!N,N',2kappa$2!N,N') (hydroxido-2kappaO)bis(miu-1- methylcytosinato-kappa$2!N3,N4) diplatinum(iii)(Pt-Pt) triperchlorate monohydrate
C14H31N10O4Pt2,3(ClO4),H2O
Dalton transactions (Cambridge, England : 2003) (2010) 39, 15 3633-3643
a=11.2503(4)Å b=12.3786(4)Å c=13.0732(5)Å
α=67.701(2)° β=70.504(2)° γ=64.629(2)°
(Ethane-1,2-diamine)bis(1- methylcytosine)platinum(ii)dinitrate dihydrate
C12H22N8O2Pt,2(NO3),2(O)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 15 3633-3643
a=10.7582(10)Å b=14.5690(17)Å c=14.0733(15)Å
α=90.00° β=101.110(6)° γ=90.00°
Chlorido(N,N'-dimethylethane-1,2-diamine)(1-methylcytosine)platinum(II) nitrate monohydrate
C9H19ClN5OPt,0.12(O8),NO3
Dalton transactions (Cambridge, England : 2003) (2010) 39, 15 3633-3643
a=12.4934(4)Å b=12.7860(4)Å c=12.6634(4)Å
α=90.00° β=118.875(2)° γ=90.00°